Osteora
Osteora
Engineered to guarantee anatomical alignment, structural stability, and superior primary healing post-sternotomy. These high-performance rigid systems address the clinical demands of complex cardiothoracic reconstructions in Genoa's leading medical facilities.
Genoa, the historic maritime core of Liguria, stands today as a focal point of medical excellence in Northern Italy. Driven by renowned research and clinical institutions like the Ospedale Policlinico San Martino and the Istituto Giannina Gaslini, Genoa requires top-tier medical device integration. With an aging demographic profile in Liguria, cardiothoracic surgical clinics confront a rising volume of coronary artery bypass grafting (CABG) and complex valve replacements requiring median sternotomies.
Traditional stainless steel wire closure methods are increasingly being superseded by advanced, rigid Sternal Fixation Systems. In osteoporotic patients or those with high risk profiles (obesity, chronic obstructive pulmonary disease, or diabetes), wire cerclage runs the danger of bone "cheese-cutting" and mechanical failure. Our advanced titanium locking plate configurations stabilize the sternum against multidirectional respiratory forces, minimizing post-surgical pain, speeding up extubation, and critically reducing instances of Deep Sternal Wound Infection (DSWI).
Osteora Medical Devices Co., Ltd. serves as an expert partner, shipping directly to Genoa-based medical device distributors, hospitals, and surgical clinics, ensuring the regional healthcare network benefits from reliable supply chain routes, clinical-grade biocompatible implants, and flexible customized solutions.
Leveraging the Port of Genoa's unparalleled Mediterranean logistics network, Osteora ensures swift import transit, streamlined customs protocols, and compliance with the Italian Ministry of Health standards.
The global cardiothoracic closure market is undergoing a significant paradigm shift. Clinical evidence in peer-reviewed orthopedic literature supports rigid fixation as the gold standard for high-risk patients. Recent multicenter clinical studies demonstrate that rigid sternal plating reduces the sternal complication rate by up to 50% compared to wire cerclage. This reduction translates directly to shorter Intensive Care Unit (ICU) stays and lowered overall hospital costs.
Sternal fixation plates distribute respiratory loads evenly across the sternum, mitigating stress concentration points that commonly cause bone fracture in wire-stabilized sternums.
With plate profiles under 1.5mm, modern titanium systems avoid post-operative palpability issues, ensuring high patient comfort without compromising torsional rigidity.
Advanced locking mechanisms allow rapid instrument-assisted removal of plates in emergent cardiovascular interventions, restoring thoracic access in under 60 seconds.
While Grade 4/5 Titanium remains the global standard for mechanical strength and osseointegration, research in polymer technologies introduces Polyetheretherketone (PEEK) for non-magnetic, radiolucent, and flexible dynamic stabilization. Sternal systems are evolving to integrate composite materials and hybrid designs. Osteora's R&D department continues to trail-blaze in bio-mechanical simulations, using finite element analysis (FEA) to model plate performance under intense coughing fits, verifying long-term cyclic fatigue resistance before any prototype enters the cleanroom.
Osteora Medical Devices Co., Ltd. is a professional orthopedic implant and surgical solution manufacturer specializing in trauma, spine, and joint reconstruction systems. Under our global brand Osteora, we design, manufacture, and distribute high-precision sternal fixation and orthopedic systems to medical hubs worldwide, including Genoa.
Founded in 2016, our modern facility spans 18,500㎡. We house state-of-the-art tooling, cleanrooms, and testing facilities to support complete end-to-end quality assurance. Backed by 12 years of industry expertise and 8 years of dedicated export experience, we maintain a robust annual export revenue of USD 6 million to 14 million.
Our operation is driven by 85 R&D engineers focused on micro-machining and bio-engineering. This allows us to supply 120 new products annually, supporting deep OEM/ODM customizations for global medical device brands.
From the sourcing of biocompatible raw materials to multi-functional mechanical testing, every process is conducted in compliance with ISO 13485 standards. Below is an overview of our state-of-the-art production floor and machinery assets:
Sternal recovery demands systems that adapt to the physiological movements of the patient's breathing cycle. Osteora’s technical roadmap prioritizes biomimetic elastic fixation. Rigid fixation plates stabilize the bone constructs, but a small degree of dynamic elasticity is beneficial to promote callus formation. Our future technical iterations involve:
By leveraging selective laser melting (SLM) technologies, we are developing patient-specific sternal implants for complex oncology reconstructions in Genoa clinics. 3D-printed titanium mesh structures allow vascularization and tissue ingrowth, accelerating reconstruction integrity.
We are engineering nano-silver and iodine-doped anodic coatings for titanium plates. These surface modifications release bactericidal agents in a controlled manner post-surgery, offering a powerful preventative measure against surgical site infections.
Explore our CE-compliant medical implants, surgical power tools, and arthroscopic fixation systems shipped globally and optimized for orthopedic trauma centers in Liguria.
Answers to critical questions asked by orthopedic surgeons, clinical purchasing departments, and medical device distributors in Genoa and Europe.
Partner with an ISO 13485 certified manufacturer. Connect with our dedicated sales engineers to receive a customized quote, detailed product catalogs, or technical compliance documents.
Send Inquiry Now
